An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 18th October, 2013
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)
School of Biological Sciences

Title: Innovation Through Callaghan
Presented by Dr Mary Quin, CEO of Callaghan Innovation and Toby Littin, Acting Regional Manager, Auckland, for Callaghan Innovation

We are confident that this month’s speakers will be of great interest to companies and organisations throughout the bioscience sector. We are delighted to welcome Dr Mary Quin, CEO of Callaghan Innovation and Toby Littin, Acting Regional Manager, Auckland, for Callaghan Innovation.

You have probably realised that Callaghan Innovation is much more than IRL by a different name, but may be unsure as to its actual role and its potential impact on your company and/or research programme. CI’s stated mission is to accelerate the commercialisation of innovation by firms in New Zealand and its top ten outcomes include delivering a portfolio of Accelerator Services ….assist firms with identifying the issues constraining their growth …..(assist firms with)developing growth strategies…evaluating firms eligibility for R&D grants and administrating grants provided.

Many of you will be aware that Mary has recently returned to New Zealand to take up the position as CEO of Callaghan Innovation after 20 years working overseas in senior executive roles in NASDAQ-listed companies such as Eastman Kodak Company and Xerox. The role includes the rather daunting challenge to build an integrated and responsive organisation that will ‘unlock the potential of New Zealand’s High Value Manufacturing and Services sector and businesses through increased commercialisation of research including science, engineering, technology and design led innovation’.

At the October forum, Mary will discuss her vision for Callaghan Innovation, including the policies and services that will be provided to facilitate commercialisation success for NZ companies. Her presentation will be followed by Toby who will focus on the allocation of the $141M p.a. in grants that CI will administer over the next three years.

All welcome. RSVPs to Margot Bethell for organisational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 923 9625 or 0274 305 758.